MORGAN STANLEY - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 29 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,950
-20.0%
19,920
+10.7%
0.00%
Q2 2023$14,944
+482.4%
18,000
+200.0%
0.00%
Q4 2022$2,566
-14.5%
6,000
-0.0%
0.00%
Q3 2022$3,000
-70.0%
6,001
-17.2%
0.00%
Q2 2022$10,0007,249
+11783.6%
0.00%
Q1 2022$0
-100.0%
61
-99.8%
0.00%
Q4 2021$237,000
+23600.0%
28,678
+28578.0%
0.00%
Q3 2021$1,0001000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders